These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2128376

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin converting enzyme inhibitors: the end of end-stage renal disease?
    Feig PU, Rutan GH.
    Ann Intern Med; 1989 Sep 15; 111(6):451-3. PubMed ID: 2672924
    [No Abstract] [Full Text] [Related]

  • 3. REIN on obesity, proteinuria and CKD.
    Choi ME.
    J Am Soc Nephrol; 2011 Jun 15; 22(6):990-2. PubMed ID: 21617125
    [No Abstract] [Full Text] [Related]

  • 4. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI, Lewis JG, Elder PA, Agarwal M.
    Clin Nephrol; 2002 Oct 15; 58(4):321-4. PubMed ID: 12400851
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease.
    Myers BD, Boothroyd D, Olshen RA.
    J Am Soc Nephrol; 1998 Dec 15; 9(12 Suppl):S66-70. PubMed ID: 11443771
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemodynamic and biological correlates of glomerular hyperfiltration in sickle cell patients before and under renin-angiotensin system blocker.
    Haymann JP, Hammoudi N, Livrozet M, Santin A, Mattioni S, Letavernier E, Frochot V, Jacques CS, Steichen O, Grateau G, Chaignon M, Lionnet F.
    Sci Rep; 2021 Jun 03; 11(1):11682. PubMed ID: 34083624
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renoprotective properties of angiotensin-converting enzyme inhibitors: proofs and limits?
    Esnault VL.
    Nephron; 2000 Jun 03; 85(2):183-4. PubMed ID: 10867528
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Further evidence for the renoprotective effect of ACE inhibitors: ramipril protects against the progression of chronic renal insufficiency in non-diabetic nephropathy with nephrotic proteinuria].
    Mayr M, Dickenmann MJ.
    Schweiz Med Wochenschr; 2000 Apr 01; 130(13):491. PubMed ID: 10812646
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of protein restriction on deterioration of kidney function].
    Gansevoort RT, de Zeeuw D, de Jong PE.
    Ned Tijdschr Geneeskd; 1997 Nov 01; 141(44):2106-10. PubMed ID: 9550772
    [Abstract] [Full Text] [Related]

  • 14. ACE inhibition and renal protection.
    Ritz E.
    Clin Physiol Biochem; 1992 Nov 01; 9(3):94-7. PubMed ID: 1302163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [ACE inhibitor effects on structure and function of the glomerular basement membrane].
    Hasslacher C, Bostedt-Kiesel A, Kempe HP.
    Klin Wochenschr; 1992 Nov 01; 69 Suppl 29():39-44. PubMed ID: 1614191
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The comparative characteristics of the renal protective properties of angiotensin-converting enzyme inhibitors and calcium channel blockers].
    Kolesnyk MO, Lapchyns'ka II, Hromova AIe, Kassyr KhI.
    Lik Sprava; 2000 Nov 01; (3-4):11-5. PubMed ID: 10921249
    [No Abstract] [Full Text] [Related]

  • 20. Progressive chronic nephropathy. With special emphasis on the influence of angiotensin converting enzyme inhibition.
    Kamper AL.
    Dan Med Bull; 1998 Apr 01; 45(2):181-94. PubMed ID: 9587702
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.